Rashmi Kumar - 02 Jun 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Director
Issuer ticker: MYGN
Reported as of: 02 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2022, 17:28:20 UTC
Prior SEC filing: 04 Jun 2021
Next SEC filing: 02 Jun 2023
Source filing: View source filing
Reporting owner signature: By: Nathan A. Smith For: Rashmi Kumar

Key filing fact

Rashmi Kumar filed Form 4 for MYRIAD GENETICS INC (MYGN) on 03 Jun 2022.

Key facts

This page summarizes Rashmi Kumar's Form 4 filing for MYRIAD GENETICS INC (MYGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2022, 17:28.

Change

Previous filing in this sequence was filed on 04 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Award

Transaction value: $0
Shares: +17,275
Change %: +47%
Price: $0.000000
Shares after: 54,046
Date: 02 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant.